Edition:
United Kingdom

Jaguar Health Inc (JAGX.OQ)

JAGX.OQ on NASDAQ Stock Exchange Capital Market

0.55USD
19 Oct 2018
Change (% chg)

$0.00 (+0.93%)
Prev Close
$0.54
Open
$0.54
Day's High
$0.55
Day's Low
$0.51
Volume
205,268
Avg. Vol
287,760
52-wk High
$6.60
52-wk Low
$0.50

Latest Key Developments (Source: Significant Developments)

Knight Therapeutics And Jaguar Health Announce Strategic Partnership
Monday, 24 Sep 2018 

Sept 24 (Reuters) - Knight Therapeutics Inc ::KNIGHT THERAPEUTICS AND JAGUAR HEALTH ANNOUNCE STRATEGIC PARTNERSHIP.KNIGHT THERAPEUTICS INC - TO BE RESPONSIBLE FOR ALL REGULATORY AND COMMERCIAL ACTIVITIES FOR MYTESI AND RELATED PRODUCTS IN LICENSED TERRITORIES.KNIGHT THERAPEUTICS - UPON ACHIEVEMENT OF REGULATORY, SALES MILESTONES IN AGREEMENT, JAGUAR TO RECEIVE PAYMENTS FROM CO OF UP TO $18.0 MILLION.KNIGHT THERAPEUTICS - AGREEMENT GRANTS CO EXCLUSIVE RIGHT TO COMMERCIALIZE MYTESI AND RELATED PRODUCTS IN CANADA AND ISRAEL.KNIGHT THERAPEUTICS INC - AGREEMENT GRANTS CO A RIGHT OF FIRST NEGOTIATION TO COMMERCIALIZE MYTESI & RELATED PRODUCTS IN SPECIFIED LATAM COUNTRIES.KNIGHT THERAPEUTICS INC - JAGUAR IS ALSO PURSUING POSSIBLE FOLLOW-ON INDICATIONS FOR MYTESI IN CANCER THERAPY-RELATED DIARRHEA.KNIGHT THERAPEUTICS - JAGUAR TO RECEIVE PAYMENTS FROM CO OF UP TO $18.0 MILLION THROUGHOUT INITIAL 15-YEAR TERM OF AGREEMENT.  Full Article

Jaguar Health Inc Files For Common Stock Offering Of Up To $11.5 Mln
Wednesday, 12 Sep 2018 

Sept 12 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH INC FILES FOR COMMON STOCK OFFERING OF UP TO $11.5 MILLION - SEC FILING.  Full Article

Jaguar Health Files For Resale Of Up To 1.23 Mln Shares
Monday, 30 Jul 2018 

July 30 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH INC FILES FOR RESALE OF UP TO 1.23 MILLION SHARES OF COMMON STOCK - SEC FILING.  Full Article

Jaguar Health Says Board Increased Size Of Board To 8 Directors
Monday, 18 Jun 2018 

June 18 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH SAYS BOARD INCREASED SIZE OF BOARD TO 8 DIRECTORS - SEC FILING.  Full Article

Jaguar Health Files For Resale Of Up To 29.4 Mln Shares Common Stock By The Selling Shareholders
Friday, 20 Apr 2018 

April 20 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH INC FILES FOR RESALE OF UP TO 29.4 MILLION SHARES COMMON STOCK BY THE SELLING SHAREHOLDERS - SEC FILING.  Full Article

Jaguar Health Files For Resale Or Other Disposition Of Up To 6.02 Mln Shares Of Voting Common Stock
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH INC FILES FOR RESALE OR OTHER DISPOSITION OF UP TO 6.02 MILLION SHARES OF VOTING COMMON STOCK - SEC FILING.  Full Article

Jaguar Health Says Unit Entered Amendment To Note Purchase Agreement
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH - ON DEC 29, 2017, UNIT ENTERED AMENDMENT TO NOTE PURCHASE AGREEMENT & NOTES WITH EACH OF PURCHASERS PARTY TO AGREEMENT DATED MARCH 1, 2017.JAGUAR HEALTH - ITS UNIT AMENDED ORIGINAL ISSUE DISCOUNT EXCHANGEABLE PROMISSORY NOTES PREVIOUSLY ISSUED TO PURCHASERS ON MARCH 1, 2017 & APRIL 27, 2017.JAGUAR HEALTH SAYS AMENDMENT LOWERS PRICE AT WHICH NOTES ARE EXCHANGEABLE FOR SHARES OF CO'S COMMON STOCK FROM $0.56/SHARE TO $0.20/SHARE - SEC FILING.JAGUAR HEALTH - AMENDMENT EXTENDS MATURITY DATE OF FIRST TRANCHE NOTES FROM DEC 1, 2017 TO FEB 15 & SECOND TRANCHE NOTES FROM JAN 27 TO APRIL 1.  Full Article

Jaguar Health ‍Enters Collaboration Agreement With SEED For Equilevia​
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH INC - ‍ENTERED COLLABORATION AGREEMENT WITH SEED MENA BUSINESSMEN SERVICES FOR EQUILEVIA​.JAGUAR HEALTH- AS PER TERMS OF DEAL, CO WILL PAY SEED ONGOING PERCENTAGE OF REVENUE GENERATED FROM ANY CLIENTS OR PARTNERS INTRODUCED TO CO BY SEED.JAGUAR HEALTH INC - ‍ ACCORDING TO TERMS OF AGREEMENT, AGREED-UPON REVENUE PERCENTAGE INCREASES AFTER FIRST ONE-MILLION DOLLARS OF REVENUE​.  Full Article

Jaguar Health enters share purchase agreement
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Jaguar Health Inc ::JAGUAR HEALTH ENTERS SHARE PURCHASE AGREEMENT FOR 2 MILLION SHARES AND COMMON STOCK PURCHASE AGREEMENT RELATING TO A 10 MILLION SHARE EQUITY LINE OFFERING WITH L2 CAPITAL, LLC.JAGUAR HEALTH-ON NOV 24,CO ENTERED SHARE PURCHASE AGREEMENT WITH L2 CAPITAL AFTER WHICH CO SOLD 2 MILLION SHARES OF VOTING COMMON STOCK AT $0.25 PER SHARE ​.  Full Article

Jaguar Health ‍signs non-binding term sheet to issue note to Iliad Research
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Jaguar Health Inc :Jaguar health enters non-binding agreement of terms to issue a secured convertible note to iliad research and trading, l.p. (an affiliate of chicago venture partners, l.p.), as jaguar expands commercial efforts for mytesi.Jaguar health inc - ‍signed a non-binding term sheet to issue to iliad research and trading, l.p. Note of $1,375,000 for purchase price of $1,100,000​.Jaguar health inc - ‍note will bear interest at rate of 8.0% per annum, with a fixed conversion price of $0.52/share​.Jaguar health inc - ‍note will be due nine months after its issue date​.  Full Article